What appears to be more unique for the KPC-3403 model compared to the KPC-4545 model is the smaller number of CAFs in the untreated control tumor and the increase of CAFs following anti-IL-1β treatment (Fig. 4). The gene discussed is IL1B; the disease is neoplasm.